About Kumovis
Kumovis is a company based in Munchen (Germany) founded in 2017 by Sebastian Pammer and Alexander Henhammer was acquired by 3D Systems in February 2022. Kumovis has raised $5.11 million across 3 funding rounds from investors including 3D Systems, RENOLIT and Solvay Start-Ups Accelerates Innovation. Kumovis offers products and services including EXT 220 MED and DMP Factory 500. Kumovis operates in a competitive market with competitors including Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.
- Headquarter Munchen, Germany
- Founders Sebastian Pammer, Alexander Henhammer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kumovis Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.11 M (USD)
in 3 rounds
-
Latest Funding Round
$3.95 M (USD), Series A
May 28, 2020
-
Investors
3D Systems
& 4 more
-
Employee Count
Not available
-
Acquired by
3D Systems
(Feb 23, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kumovis
Kumovis offers a comprehensive portfolio of products and services, including EXT 220 MED and DMP Factory 500.
Printer for manufacturing medical implants with high-performance polymers.
System for direct metal printing in manufacturing applications.
People of Kumovis
Unlock access to complete
Funding Insights of Kumovis
Kumovis has successfully raised a total of $5.11M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.95 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kumovis
Kumovis has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include 3D Systems, RENOLIT and Solvay Start-Ups Accelerates Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Accelerator firm backed by Solvay
|
Locked | Locked | Locked | |
|
Startups are incubated with space technology and business support.
|
Locked | Locked | Locked |
Investor details for Kumovis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kumovis
Investment portfolio details for Kumovis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kumovis
Detailed financials for Kumovis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kumovis Comparisons
Peer comparison for Kumovis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kumovis
Kumovis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Multiplex protein stability platform for biologics is developed.
|
Detailed competitors of Kumovis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kumovis
Complete news archive for Kumovis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumovis
Kumovis was founded in 2017.
Kumovis is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Kumovis is a funded company, having raised a total of $5.11M across 3 funding rounds to date.
Kumovis was founded in 2017 in Munich, Germany, as a developer of 3D-printing systems targeted at life science sectors. Operations center on the KUMOVIS R1 platform, which employs Fused Filament Fabrication to process thermoplastic materials. Development efforts emphasize polymers including polyether ether ketone for medical and industrial applications. The company operates from its base in Europe, supporting advancements in personalized manufacturing.
Kumovis's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.
Kumovis offers EXT 220 MED and DMP Factory 500.
Kumovis has 5 investors. Key investors include 3D Systems, RENOLIT, Solvay Start-Ups Accelerates Innovation, High-Tech Gründerfonds, and ESA BIC.